Antisoma stages comeback with promising cancer drugs
May 20, 2010Research and Development AML, Antisoma, chemotherapy, leukaemia
UK biotech Antisoma is looking to put previous late-stage trial failures behind it by focusing on two new cancer drugs. …
Publicis acquires Resolute Communications
May 20, 2010Medical Communications Resolute, publicis
French-based communications group Publicis has acquired independent UK healthcare communications agency Resolute Communications. London-based Resolute will be merged with Publicis …
Jeff Solomon joins Biosciences NEDs
May 20, 2010Business Services Bioscience NEDs, Chairman, Life science, NED, Non Executive Director, appointment, bioscience, business services, recruitment
Jeff Solomon has joined Bioscience NEDs as a non-executive advisor.He is currently chairman of the Council for European Bioregions and a non-executive director …
Recession makes UK pharma employees more loyal
May 20, 2010Business Services careers, recruitment
A new survey shows pharma employees are now more loyal despite turbulent economic changes within the industry. Conducted by recruitment …
Working Life: Dr John Sinden
May 19, 2010Research and Development ReNeuron, Working Life, career
ReNeuron’s chief scientific officer discusses his career to date. How did you find your way into your current role?
India revokes Roche’s Valcyte patent
May 19, 2010Sales and Marketing India, Roche, patents
Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …
Pfizer takes the axe to manufacturing operations
May 19, 2010Manufacturing and Production Pfizer, job cuts, manufacturing
Pfizer is to reduce manufacturing staffing by around 6,000 – around 18% of its total production workforce – and close …
Chiltern Announces new Offices and Expansion Plans in Asia Pacific
May 19, 2010Research and Development
This builds further upon Chiltern’s well established operation in India. Chiltern is also in the process of forming a company …
UCB’s Roch Doliveux joins Innovative Medicines Initiative board
May 19, 2010Research and Development UCB, appointment, research and development
UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …
Spain to cut prescription drug prices
May 19, 2010Sales and Marketing Spain, industry, prices
The Spanish government will cut the prices of patented prescription drugs from 1 August in a bid to save 1.3 …
New healthcare marketing services firm launched
May 19, 2010Medical Communications, Sales and Marketing PharmaGems, market research, marketing
A new business aimed at helping entrepreneurs and run by two former directors of Synovate Healthcare has launched in London. …
Steve Howson to lead Ferring UK
May 18, 2010Research and Development, Sales and Marketing Ferring, appointment, research and development, sales and marketing
Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …
UK appoints interim chief medical officer
May 18, 2010NHS, UK, appointment
Professor Dame Sally Davies will take on the role of interim chief medical officer when Sir Liam Donaldson retires as …
EMA eyes stem cell research breakthrough
May 18, 2010Research and Development EMA, Stem cells, stem cell
European regulators are readying themselves to deal with the region’s first marketing authorisation application for a stem cell product. The …
Pfizer signs ground-breaking academic research deal
May 18, 2010Research and Development Pfizer, US, academia, clinical research
Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …
Bayer opens US ‘science hub’
May 18, 2010Research and Development Bayer, US, acdemia, clinical research
Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …
Merck’s Brinavess performs in phase III
May 18, 2010Research and Development Brinavess, Merck & Co, atrial fibrilation
Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …
Lansley warns of deeper NHS cuts
May 17, 2010NHS, NHS funding, election, government
Health Secretary Andrew Lansley has warned the NHS may face deeper cuts than expected. Lansley, who was appointed Health Secretary …
FDA says rotavirus vaccines are safe
May 17, 2010Manufacturing and Production drug safety, rotarix, rotateq
The US Food and Drug Administration has taken the advice of its advisors and given its backing to resume the …
New global ‘polypill’ trials start
May 17, 2010Research and Development Dr Reddy, hypertension, polypill, statin
New trials of a daily polypill – combining aspirin, a statin and two blood pressure lowering medicines – are underway …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
